Cite
MLA Citation
J. Choi et al.. “Assessment of Tocilizumab (Anti–Interleukin‐6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody‐Mediated Rejection and Transplant Glomerulopathy in HLA‐Sensitized Renal Allograft Recipients.” American journal of transplantation, vol. 17, no. 9, 2017, pp. 2381–2389. http://access.bl.uk/ark:/81055/vdc_100048654443.0x000037